Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics as a novel approach to treating autoimmune conditions
Caitlin Thompson, Attila Szabó
Immunology Letters (2020) Vol. 228, pp. 45-54
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Psychedelic medicines for mood disorders: current evidence and clinical considerations
Jerome Sarris, Diego Pinzon Rubiano, Kimberley Day, et al.
Current Opinion in Psychiatry (2021) Vol. 35, Iss. 1, pp. 22-29
Closed Access | Times Cited: 22
Beating pain with psychedelics: Matter over mind?
Igor Elman, Amanda C. Pustilnik, David Borsook
Neuroscience & Biobehavioral Reviews (2021) Vol. 134, pp. 104482-104482
Closed Access | Times Cited: 21
Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey
Valérie Bonnelle, William Smith, Natasha L. Mason, et al.
British Journal of Pain (2022) Vol. 16, Iss. 6, pp. 619-631
Open Access | Times Cited: 16
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics
Robert H. Dworkin, B. Anderson, Nick Andrews, et al.
Journal of Pain (2022) Vol. 23, Iss. 10, pp. 1666-1679
Closed Access | Times Cited: 14
Bedside to bench: the outlook for psychedelic research
Victor P. Acero, Emily S. Cribas, Kevin D. Browne, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review
Ron Shore, K. Dobson, Nina Thomson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
Daniel A Kinderlehrer
International Medical Case Reports Journal (2023) Vol. Volume 16, pp. 109-115
Open Access | Times Cited: 6
Classic psychedelics do not affect T cell and monocyte immune responses
Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies
Patrick Fissler, Anja Vandersmissen, Marco Filippi, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 679-686
Closed Access | Times Cited: 5
Psychedelic medicines for mood disorders: current evidence and clinical considerations.
Jerome Sarris, Diego Pinzon Rubiano, Kimberley Day, et al.
(2021) Vol. 35, Iss. 1, pp. 22-29
Closed Access | Times Cited: 11
Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties
Matteo Politi, Giorgia Tresca, Luigi Menghini, et al.
Planta Medica (2021) Vol. 88, Iss. 14, pp. 1275-1286
Open Access | Times Cited: 10
Psychedelics and fNIRS neuroimaging: exploring new opportunities
Felix Scholkmann, Franz X. Vollenweider
Neurophotonics (2022) Vol. 10, Iss. 01
Open Access | Times Cited: 7
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis
Noah D. Gold, Austin Mallard, Jacob C. Hermann, et al.
Journal of Palliative Medicine (2023) Vol. 26, Iss. 10, pp. 1408-1418
Closed Access | Times Cited: 2
Attention
Aidan Lyon
Oxford University Press eBooks (2023), pp. 94-129
Closed Access | Times Cited: 2
Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
Rabeet Tariq
Current Reviews in Clinical and Experimental Pharmacology (2022) Vol. 18, Iss. 2, pp. 94-109
Closed Access | Times Cited: 4
1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?
Sylvana Vilca-Melendez, Malin V. Uthaug, Julian L. Griffin
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 4
Design and Methodology of the First Open-Label Trial of MDMA-Assisted Therapy for Veterans with Post-Traumatic Stress Disorder and Alcohol Use Disorder: Considerations for a Randomized Controlled Trial
Erica Eaton, Christy Capone, Brian J. Gully, et al.
Contemporary Clinical Trials Communications (2024) Vol. 41, pp. 101333-101333
Open Access
Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis
Giorgia Caspani, Simon Ruffell, WaiFung Tsang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107338-107338
Open Access
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective
Donatella Marazziti, Francesco Weiss, Riccardo Gurrieri, et al.
Expert Review of Neurotherapeutics (2024)
Closed Access
Reverse engineering therapeutic mechanisms of ketamine and Psychedelics: Insights from Translational Oncology for Research in Psychiatry
Elizabeth E. Klettke, Miles D. Holmes, Thomas D. Meyer, et al.
Personalized Medicine in Psychiatry (2023) Vol. 41-42, pp. 100112-100112
Closed Access | Times Cited: 1
Alzheimer’s disease, dementia, aging, and COVID-19
Elena L. Paley
Elsevier eBooks (2023), pp. 291-307
Closed Access
Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress
Noah D. Gold, Samantha K. Podrebarac, Lindsay A. White, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 2, pp. 87-97
Closed Access
Unlocking the potential of psychedelics as medicine: Past obstacles and future outlooks
Sharon Kim, Rayven-Nikkita Collins, Jimmy Teng, et al.
(2023) Vol. 4, pp. 88-101
Open Access
Mystical Experience
Aidan Lyon
Oxford University Press eBooks (2023), pp. 255-294
Closed Access

Scroll to top